The status of pharmacotherapy for autism spectrum disorders
about
Mental health services for individuals with high functioning autism spectrum disorderTherapeutic approaches for shankopathiesMecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disordersOxidative pathways as a drug target for the treatment of autismA longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disordersCo-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment.Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.Mass spectrometry as a tool for studying autism spectrum disorder.Autism: an emerging 'neuroimmune disorder' in search of therapy.Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.Evidence review and clinical guidance for the use of ziprasidone in Canada.Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional AnalysisAtomoxetine for treating ADHD symptoms in autism: a systematic review.The use of antipsychotics in preschoolers: a veto or a sensible last option?Psychotropic drug treatments for people with autism and other developmental disorders: a primer for practicing behavior analystsEffects of Combining Medication and Pivotal Response Treatment on Aberrant Behavior in Children with Autism Spectrum Disorder.Medical Conditions and Demographic, Service and Clinical Factors Associated with Atypical Antipsychotic Medication Use Among Children with An Autism Spectrum Disorder.Comparing residential programmes for adults with autism spectrum disorders and intellectual disability: outcomes of challenging behaviour and quality of life.Efficacy of atomoxetine for the treatment of ADHD symptoms in patients with pervasive developmental disorders: a prospective, open-label study.Impact of employee benefits on families with children with autism spectrum disorders.
P2860
Q26828583-92F2AA89-B7FA-40E5-AEC5-B6E65C07D519Q27024976-CE485DE3-4FC3-49D5-A825-DAE64354076DQ28263028-57E93D78-28F6-405F-BA7F-AA86A041D0B5Q28295948-459997B6-EA83-4ACE-91E5-678AA210820AQ33690844-69EADF12-7533-402B-8B9C-55C2A546FA53Q34011138-B1F44E57-21E6-4957-8275-E0518D354616Q34424843-ED7CADE5-D3DF-4687-83AB-AF3D73001C7BQ34470350-EAD4BE1B-94C4-41C3-9AA3-5F444A5A1D47Q34994653-EB7C79F9-7F42-4420-A2FF-B068068C8C00Q35641660-7954CEF9-3B68-49C3-BDBE-2790C0A8D282Q36588607-AD4FC66D-F20E-4B30-A6BF-F43D4DFC8F59Q37452761-55BAE2BE-AA38-406F-A558-3F7A97F94A82Q38006416-49421729-8689-43FF-B17A-E30F8713F598Q38180865-A7C137A6-9C31-4274-9BC2-2BE91F014521Q41247017-0D9CF7D3-3D6A-44A4-A566-2220F85A2AC2Q47550289-0914C5C8-DAF8-4024-9561-B42144F8BBF0Q47762744-00AF9FD1-8024-482F-B7CB-02AFB94E9120Q48619804-620893F9-CCC5-4464-BE76-24E64A37EC99Q50308324-D1E61935-BEED-45F7-8B43-D68E10EB2E19Q50345589-8E3E49AF-1AD0-4C9A-BA96-48AD727A5D62
P2860
The status of pharmacotherapy for autism spectrum disorders
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The status of pharmacotherapy for autism spectrum disorders
@ast
The status of pharmacotherapy for autism spectrum disorders
@en
The status of pharmacotherapy for autism spectrum disorders
@nl
type
label
The status of pharmacotherapy for autism spectrum disorders
@ast
The status of pharmacotherapy for autism spectrum disorders
@en
The status of pharmacotherapy for autism spectrum disorders
@nl
prefLabel
The status of pharmacotherapy for autism spectrum disorders
@ast
The status of pharmacotherapy for autism spectrum disorders
@en
The status of pharmacotherapy for autism spectrum disorders
@nl
P2860
P921
P1476
The status of pharmacotherapy for autism spectrum disorders
@en
P2093
Scott M Myers
P2860
P304
P356
10.1517/14656566.8.11.1579
P407
P577
2007-08-01T00:00:00Z